Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ISRCTN72336993) titled 'The prevention of respiratory tract infections offered by oral administration of the bacterial lysate-OM-85 is extended to asthma symptoms, exacerbations, and need for oral corticosteroids' on Dec. 16, 2025.
Study Type: Observational
Study Design:
Cohort study
Primary Sponsor: Asthma Clinics Specialist Care Practices Greece
Condition:
Severe bronchial asthma
Respiratory
Intervention:
Post hoc analysis of the OMRIA RWE study (https://doi.org/10.2147/jaa.s517194). In this analysis, the researchers used a four-component clinical-remission definition. Patients were required to meet all of the following criteria...